| Bioactivity | Tertiapin (reduced) is a kind of synthesis of melittin, its Cys3-Cys14 and Cys5-Cys18 between containing a disulfide bond. Tertiapin (reduced) is a kind of inward rectifier potassium channels blockers, can block the activity of calcium activates large conductance potassium channels. Tertiapin (reduced) can be used for research in diseases such as rheumatoid arthritis and multiple sclerosis[1]. |
| CAS | 58694-52-3 |
| Sequence | Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Met-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2 |
| Shortening | ALCNCNRIIIPHMCWKKCGKK-NH2 |
| Formula | C106H180N34O23S5 |
| Molar Mass | 2459.10 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kitamura H, et al. Tertiapin potently and selectively blocks muscarinic K+ channels in rabbit cardiac myocytes[J]. Journal of Pharmacology and Experimental Therapeutics, 2000, 293(1): 196-205. |
Tertiapin (reduced)
CAS: 58694-52-3 F: C106H180N34O23S5 W: 2459.10
Tertiapin (reduced) is a kind of synthesis of melittin, its Cys3-Cys14 and Cys5-Cys18 between containing a disulfide bon
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.